Stamer President-Elect for ARVO

Monday, April 30, 2018

W. Daniel Stamer, PhD, FARVO is the 2019 president-elect of The Association for Research in Vision and Ophthalmology (ARVO).  Stamer has been serving as an ARVO trustee representing the Physiology/Pharmacology (PH) Section for the past 3 years. 

The PH Section of ARVO is one of 13 Scientific Sections and covers three areas of research: systemic tissue cellular and molecular physiology and pharmacology; ocular pathophysiology and disease; and pharmacological mechanisms including drug delivery/disposition and related bioengineering. He was elected during the ARVO Trustee Meeting at the Annual Meeting taking place in Honolulu, HI. 

ARVO is the largest and most respected eye and vision research organization in the world, with membership of nearly 12,000 researchers from over 75 countries. 

Stamer is the Joseph A.C. Wadsworth Professor of Ophthalmology and Professor of Biomedical Engineering at Duke University School of Medicine.  His laboratory studies the disease of glaucoma using molecular, cellular and organ-based model systems, and seeks to identify and validate novel drug targets in the human conventional outflow pathway, such that novel treatment of ocular hypertension and glaucoma can be developed.